Clinical Portfolio | TB Alliance

]

Phase 1

TBAJ-587
TBAJ-587 / Diarylquinoline
ERA4TB
TBAJ-876
TBAJ-876
TBI-223
TBI-223 / Oxazolidinone
Institute of Materia Medica

Phase 2

BPaMZ/SEM
Bedaquiline / Pretomanid / Moxifloxacin / Pyrazinamide BPaMZ
University of St. Andrews
Sutezolid
Sutezolid / Oxazolidinone
Bill & Melinda Gates Medical Research Institute
TBA-7371
TBA-7371 / DprE1 Inhibitor
Foundation for Neglected Disease Research, Bill & Melinda Gates Medical Research Institute

Phase 3

SimpliciTB
Bedaquiline / Pretomanid / Moxifloxacin / Pyrazinamide BPaMZ
PanACEA, Radboud University, Viatris
ZeNix
Bedaquiline / Pretomanid / Linezolid BPaL
Viatris

Phase 4

Pediatric Formulation Development
Pretomanid
IMPAACT, Viatris
Optimized First-Line Drugs in Children >5kg
Ethambutol

Pyrazinamide

Isoniazid